February 12, 2026

Leukemia Case Prompts Broader Review

Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.

Conexiant

February 09, 2026

Poststroke Spasticity, Seen Too Late

New guidance from the American Heart Association addresses delayed recognition of poststroke spasticity and outlines opportunities to improve timing of rehabilitation care.

Conexiant

February 09, 2026

Coffee, Tea Linked to Lower Dementia Risk

Caffeinated beverages were associated with modest cognitive benefits in long-term study

Conexiant

February 04, 2026

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 30, 2026

Alzheimer Biomarkers Higher in Women

Researchers identify sex-specific differences in amyloid, tau, and brain structure during the seventh decade of life.

Conexiant

January 28, 2026

Medical Oddities: When Body Fat Gets to Your Head

From colds to cognition, these studies show how everyday science—viruses, fat, bones, herbs, even AI— meets fine the print.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 20, 2026

APOE Utilization Tied to Most AD Cases

Apolipoprotein E ε3 and ε4 genotypes account for most Alzheimer's disease and nearly half of all-cause dementia.*

Conexiant